AI in Medical Diagnostics Market Size is Estimated to be USD 11.5 Billion by 2034; Increasing Demand for Early and Accurate Diagnosis Accelerates Market Growth

Download Sample

Published Date: December 2024

AI in medical diagnostics market represents a transformative shift in healthcare, leveraging artificial intelligence to enhance diagnostic accuracy, efficiency, and accessibility. AI technologies are being integrated into various diagnostic tools and systems, aiding healthcare professionals in early disease detection, personalized treatment planning, and workflow optimization, which further boosts the AI in medical diagnostics market growth.

AI in Medical Diagnostics Market Segmentation Analysis:

By Component	Software, Hardware, and Services
By Application	In Vitro Diagnostics, Diagnostic Imaging, and Others
By End-User	Hospitals, Diagnostic Imaging Centers, Diagnostic Laboratories, and Others

AI in Medical Diagnostics Market Report Highlights:

AI in medical diagnostics market size accounted for USD 1.5 billion in 2024.
Target Market estimated to be USD 11.5 billion by 2034 and to register a CAGR of 25.1%.
Based on component, AI in medical diagnostics market is being led by the software segment.
According to application, the diagnostic imaging segment holds a large AI in medical devices market share.
On the basis of end-user, the hospital segment to hold a dominant share in the AI in medical diagnostics market.
By region, the AI in medical diagnostics market is expected to expand rapidly in the North American region.

AI in Medical Diagnostics Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Rising Incidence of Chronic Diseases	Reluctance to Adopt AI Technologies	Increased Adoption of Cloud-Based Solutions

AI in Medical Diagnostics Market Key Highlights:

In May 2024, iHridAI, a Bengaluru-based healthcare technology startup focused on developing benchmarked and viable technology solutions for healthcare diagnostics, launched its flagship product, HarmonyCVI, for detailed and accurate cardiovascular assessments. HarmonyCVI is a comprehensive artificial intelligence (AI)/machine learning (ML)-based rapid diagnostics and insights tool that aids cardiologists and radiologists in enhanced analysis of cardiac MRI scans.

AI in Medical Diagnostics Market Report Analysis:

Domesticating AI in Medical Diagnosis:

According to a research report published by Elsevier B.V., in March 2024, significant governmental and corporate investments in AI for healthcare, particularly diagnosis, have been spurred by the recent remarkable advancements in machine learning that raised expectations globally. Numerous exciting local partnerships between academic AI experts and doctors have led to the emergence of a plethora of intriguing applications.

Browse ∼50 market data tables and ∼55 figures through ∼170 slides and in-depth TOC on “AI in Medical Diagnostics Market, By Component (Software, Hardware, and Services), By Application (In Vitro Diagnostics, Diagnostic Imaging, and Others), By End-User (Hospitals, Diagnostic Imaging Centers, Diagnostic Laboratories, and Others), and By Region - Trends, Analysis, and Forecast till 2034”

For more insights into the AI in Medical Diagnostics market and its future trends, visit the link: https://www.prophecymarketinsights.com/market_insight/ai-in-medical-diagnostics-market-5304

Competitive Landscape of AI in Medical Diagnostics Market:

The prominent players operating in the AI in medical diagnostics market include Siemens Healthineers, Zebra Medical Vision, Inc., Riverain Technologies, Vuno, Inc., Aidoc, Neural Analytics, Imagen Technologies, Digital Diagnostics, Inc., GE Healthcare, AliveCor Inc., Microsoft, NVIDIA Corporation, and Merative.